價(jià)格 | ¥131 | ¥298 | ¥495 |
包裝 | 1mg | 5mg | 10mg |
最小起訂量 | 1mg |
發(fā)貨地 | 上海 |
更新日期 | 2024-12-12 |
中文名稱:化合物 SKA-31 | 英文名稱:SKA-31 |
CAS:40172-65-4 | 品牌: TargetMol |
產(chǎn)地: 美國 | 保存條件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
純度規(guī)格: 99.38% | 產(chǎn)品類別: 抑制劑 |
貨號(hào): T5180 |
名稱 | SKA-31 |
描述 | SKA-31 (Naphtho[1,2-d]thiazol-2-ylamine) is an activator of KCa3.1 and KCa2 channels (EC50s: 260, 2900, 2900 nM for KCa3.1, KCa2.1 and KCa2.2 respectively). |
細(xì)胞實(shí)驗(yàn) | Jurkat E61 and MEL cells were seeded at 10^5 cells/ml in 12-well plates. SKA-31 was added at concentrations of 10 and 100 μM in a final DMSO concentration of 0.1%, which was found not to affect cell viability. After 48 h, the cells in each well were well mixed and resuspended, and the number of trypan blue-positive cells in three aliquots from each well was determined under a light microscope. The test was repeated twice [1]. |
動(dòng)物實(shí)驗(yàn) | For intravenous injection, SKA-31 was dissolved at 10 mg/ml in a mixture of 10% Cremophor EL and 90% saline and injected at 10 mg/kg. For intraperitoneal application, SKA-31 was dissolved at 10 mg/ml in Miglyol 812 neutral oil (caprylic/capric triglyceride). After tail vein injection of the aqueous solution or intraperitoneal administration of the oily solution, approximately 200 μl of blood was collected from the tail into EDTA blood sample collection tubes at various time points. For very early time points (3, 5, and 10 min) after intravenous administration, blood samples were obtained by cardiac puncture under deep isoflurane anesthesia. Plasma was separated by centrifugation and stored at -80°C pending analysis. After determining that SKA-31 plasma concentrations peaked 2 h after application (10 mg/kg i.p.), we took blood samples under deep isoflurane anesthesia by cardiac puncture from a group of three rats before sacrificing the animals to remove brain, heart, liver, spleen, and fat. Tissue samples were homogenized in 1 ml of H2O with a homogenizer, and the protein was precipitated with 1 ml of acetonitrile. The samples were then centrifuged at 3000 rpm, and supernatants were concentrated to 1 ml. Plasma and homogenized tissue samples were purified using C18 solid-phase extraction cartridges. Elution fractions corresponding to SKA-31 were evaporated to dryness under nitrogen and dissolved in acetonitrile [1]. |
體外活性 | SKA-31能夠激活KCa2.1,其EC(50)值為2.9 microM;KCa2.2的EC(50)值為1.9 microM;KCa2.3的EC(50)值為2.9 microM;以及KCa3.1的EC(50)值為260 nM。SKA-31在小鼠內(nèi)皮細(xì)胞中激活了天然的KCa2.3和KCa3.1通道[1]。SKA-31 (1 μM)能夠激活KCa3.1以及KCa2.3通道,并在野生型CAEC中引起膜超極化(ΔMP -45 mV)。SKA-31(200 nM、500 nM)顯著增強(qiáng)了野生型中EDHF引起的血管舒張[2]。 |
體內(nèi)活性 | 給予10和30 mg/kg的SKA-31可以分別將正常血壓小鼠的平均動(dòng)脈血壓降低4和6 mm Hg,并且在由血管緊張素II引起的高血壓中可以降低12 mm Hg [2]。SKA-31 (10 μM) 在陰囊的微血管及中腦動(dòng)脈中抑制肌肉舒張力分別高達(dá)80%和約65%,兩種血管的IC50值均約為2 μM [3]。 |
存儲(chǔ)條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度 | DMSO : 30 mg/mL (150 mM) |
關(guān)鍵字 | inhibit | Potassium Channel | KcsA | Inhibitor | SKA-31 |
相關(guān)產(chǎn)品 | Cloperastine hydrochloride | Quinine sulfate dihydrate | Minoxidil | 2,2,2-Trichloroethanol | Minoxidil sulfate | Tetraethylammonium bromide | Indapamide | Ursodeoxycholic acid | (±)-Naringenin | Butamben | Halothane | Hydrochlorothiazide |
相關(guān)庫 | 神經(jīng)保護(hù)化合物庫 | 經(jīng)典已知活性庫 | 抗癌化合物庫 | 已知活性化合物庫 | 鉀通道分子庫 | NO PAINS 化合物庫 | 離子通道庫 | 膜蛋白靶向化合物庫 | 疼痛相關(guān)化合物庫 |
成立日期 | 2013-04-18 (12年) | 注冊(cè)資本 | 566.265100萬人民幣 |
員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1億以上 |
主營行業(yè) | 天然產(chǎn)物,生化試劑,分子生物學(xué),分子砌塊,生物技術(shù)服務(wù) | 經(jīng)營模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
---|---|---|---|---|
詢價(jià) |
VIP3年
|
普善實(shí)業(yè)(陜西)有限公司
|
2025-01-21 | |
¥680.90 |
VIP13年
|
上海阿拉丁生化科技股份有限公司
|
2025-01-20 | |
詢價(jià) |
VIP3年
|
陜西締都醫(yī)藥化工有限公司
|
2025-01-03 |